Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1989 Jan;48(1):1–6. doi: 10.1136/ard.48.1.1

Hormones and the immune response.

A K Bhalla 1
PMCID: PMC1003666  PMID: 2647048

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe E., Miyaura C., Tanaka H., Shiina Y., Kuribayashi T., Suda S., Nishii Y., DeLuca H. F., Suda T. 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5583–5587. doi: 10.1073/pnas.80.18.5583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams J. S., Sharma O. P., Gacad M. A., Singer F. R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983 Nov;72(5):1856–1860. doi: 10.1172/JCI111147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Amento E. P., Bhalla A. K., Kurnick J. T., Kradin R. L., Clemens T. L., Holick S. A., Holick M. F., Krane S. M. 1 alpha,25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J Clin Invest. 1984 Mar;73(3):731–739. doi: 10.1172/JCI111266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Amento E. P. Vitamin D and the immune system. Steroids. 1987 Jan-Mar;49(1-3):55–72. doi: 10.1016/0039-128x(87)90079-1. [DOI] [PubMed] [Google Scholar]
  5. Ansar Ahmed S., Penhale W. J., Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol. 1985 Dec;121(3):531–551. [PMC free article] [PubMed] [Google Scholar]
  6. Ausiello C. M., Roda L. G. Leu-enkephalin binding to cultured human T lymphocytes. Cell Biol Int Rep. 1984 Feb;8(2):97–106. doi: 10.1016/0309-1651(84)90076-6. [DOI] [PubMed] [Google Scholar]
  7. Bar-Shavit Z., Noff D., Edelstein S., Meyer M., Shibolet S., Goldman R. 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcif Tissue Int. 1981;33(6):673–676. doi: 10.1007/BF02409507. [DOI] [PubMed] [Google Scholar]
  8. Barbour G. L., Coburn J. W., Slatopolsky E., Norman A. W., Horst R. L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med. 1981 Aug 20;305(8):440–443. doi: 10.1056/NEJM198108203050807. [DOI] [PubMed] [Google Scholar]
  9. Besedovsky H. O., del Rey A. E., Sorkin E. Immune-neuroendocrine interactions. J Immunol. 1985 Aug;135(2 Suppl):750s–754s. [PubMed] [Google Scholar]
  10. Bhalla A. K., Amento E. P., Clemens T. L., Holick M. F., Krane S. M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983 Dec;57(6):1308–1310. doi: 10.1210/jcem-57-6-1308. [DOI] [PubMed] [Google Scholar]
  11. Bhalla A. K., Amento E. P., Krane S. M. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol. 1986 Apr 1;98(2):311–322. doi: 10.1016/0008-8749(86)90291-1. [DOI] [PubMed] [Google Scholar]
  12. Bhalla A. K., Amento E. P., Serog B., Glimcher L. H. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol. 1984 Oct;133(4):1748–1754. [PubMed] [Google Scholar]
  13. Blalock J. E., Smith E. M. A complete regulatory loop between the immune and neuroendocrine systems. Fed Proc. 1985 Jan;44(1 Pt 1):108–111. [PubMed] [Google Scholar]
  14. Blalock J. E., Smith E. M. Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity. Biochem Biophys Res Commun. 1981 Jul 30;101(2):472–478. doi: 10.1016/0006-291x(81)91284-5. [DOI] [PubMed] [Google Scholar]
  15. Bucala R., Lahita R. G., Fishman J., Cerami A. Anti-oestrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematosus. Clin Exp Immunol. 1987 Jan;67(1):167–175. [PMC free article] [PubMed] [Google Scholar]
  16. Bucala R., Lahita R. G., Fishman J., Cerami A. Increased levels of 16 alpha-hydroxyestrone-modified proteins in pregnancy and in systemic lupus erythematosus. J Clin Endocrinol Metab. 1985 May;60(5):841–847. doi: 10.1210/jcem-60-5-841. [DOI] [PubMed] [Google Scholar]
  17. Carr D. J., Klimpel G. R. Enhancement of the generation of cytotoxic T cells by endogenous opiates. J Neuroimmunol. 1986 Jul;12(1):75–87. doi: 10.1016/0165-5728(86)90099-8. [DOI] [PubMed] [Google Scholar]
  18. Cohen J. H., Danel L., Cordier G., Saez S., Revillard J. P. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol. 1983 Dec;131(6):2767–2771. [PubMed] [Google Scholar]
  19. Cutolo M., Balleari E., Accardo S., Samanta E., Cimmino M. A., Giusti M., Monachesi M., Lomeo A. Preliminary results of serum androgen level testing in men with rheumatoid arthritis. Arthritis Rheum. 1984 Aug;27(8):958–959. doi: 10.1002/art.1780270821. [DOI] [PubMed] [Google Scholar]
  20. Cutolo M., Balleari E., Giusti M., Monachesi M., Accardo S. Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol. 1986 Dec;13(6):1019–1023. [PubMed] [Google Scholar]
  21. Danek A., O'Dorisio M. S., O'Dorisio T. M., George J. M. Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol. 1983 Sep;131(3):1173–1177. [PubMed] [Google Scholar]
  22. Famaey J. P., Appelboom T., Wybran J. The nervous system and the pathophysiology of rheumatoid arthritis: the role of neurotensin and opioid peptides. J Rheumatol. 1986 Jun;13(3):651–652. [PubMed] [Google Scholar]
  23. Farrar W. L., Hill J. M., Harel-Bellan A., Vinocour M. The immune logical brain. Immunol Rev. 1987 Dec;100:361–378. doi: 10.1111/j.1600-065x.1987.tb00539.x. [DOI] [PubMed] [Google Scholar]
  24. Fontana A., Frei K., Bodmer S., Hofer E. Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue. Immunol Rev. 1987 Dec;100:185–201. doi: 10.1111/j.1600-065X.1987.tb00532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Fujita T., Matsui T., Nakao Y., Watanabe S. T lymphocyte subsets in osteoporosis. Effect of 1-alpha hydroxyvitamin D3. Miner Electrolyte Metab. 1984;10(6):375–378. [PubMed] [Google Scholar]
  26. Gilman S. C., Schwartz J. M., Milner R. J., Bloom F. E., Feldman J. D. beta-Endorphin enhances lymphocyte proliferative responses. Proc Natl Acad Sci U S A. 1982 Jul;79(13):4226–4230. doi: 10.1073/pnas.79.13.4226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Grossman C. J. Regulation of the immune system by sex steroids. Endocr Rev. 1984 Summer;5(3):435–455. doi: 10.1210/edrv-5-3-435. [DOI] [PubMed] [Google Scholar]
  28. Harbour-McMenamin D., Smith E. M., Blalock J. E. Bacterial lipopolysaccharide induction of leukocyte-derived corticotropin and endorphins. Infect Immun. 1985 Jun;48(3):813–817. doi: 10.1128/iai.48.3.813-817.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Heijnen C. J., Bevers C., Kavelaars A., Ballieux R. E. Effect of alpha-endorphin on the antigen-induced primary antibody response of human blood B cells in vitro. J Immunol. 1986 Jan;136(1):213–216. [PubMed] [Google Scholar]
  30. Hiestand P. C., Mekler P., Nordmann R., Grieder A., Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2599–2603. doi: 10.1073/pnas.83.8.2599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Holdstock G., Chastenay B. F., Krawitt E. L. Effects of testosterone, oestradiol and progesterone on immune regulation. Clin Exp Immunol. 1982 Feb;47(2):449–456. [PMC free article] [PubMed] [Google Scholar]
  32. Iho S., Takahashi T., Kura F., Sugiyama H., Hoshino T. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol. 1986 Jun 15;136(12):4427–4431. [PubMed] [Google Scholar]
  33. Johnson H. M., Torres B. A., Smith E. M., Dion L. D., Blalock J. E. Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol. 1984 Jan;132(1):246–250. [PubMed] [Google Scholar]
  34. Jungers P., Kuttenn F., Liote F., Pelissier C., Athea N., Laurent M. C., Viriot J., Dougados M., Bach J. F. Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. Arthritis Rheum. 1985 Nov;28(11):1243–1250. doi: 10.1002/art.1780281108. [DOI] [PubMed] [Google Scholar]
  35. Kay C. R., Wingrave S. J. Oral contraceptives and rheumatoid arthritis. Lancet. 1983 Jun 25;1(8339):1437–1437. doi: 10.1016/s0140-6736(83)92378-4. [DOI] [PubMed] [Google Scholar]
  36. Kiess W., Butenandt O. Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization. J Clin Endocrinol Metab. 1985 Apr;60(4):740–746. doi: 10.1210/jcem-60-4-740. [DOI] [PubMed] [Google Scholar]
  37. Koeffler H. P., Reichel H., Bishop J. E., Norman A. W. gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun. 1985 Mar 15;127(2):596–603. doi: 10.1016/s0006-291x(85)80202-3. [DOI] [PubMed] [Google Scholar]
  38. Koff W. C., Dunegan M. A. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J Immunol. 1985 Jul;135(1):350–354. [PubMed] [Google Scholar]
  39. Koren R., Ravid A., Liberman U. A., Hochberg Z., Weisman Y., Novogrodsky A. Defective binding and function of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. J Clin Invest. 1985 Nov;76(5):2012–2015. doi: 10.1172/JCI112201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Lahita R. G., Bradlow H. L., Kunkel H. G., Fishman J. Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab. 1981 Jul;53(1):174–178. doi: 10.1210/jcem-53-1-174. [DOI] [PubMed] [Google Scholar]
  41. Lahita R. G., Bucala R., Bradlow H. L., Fishman J. Determination of 16 alpha-hydroxyestrone by radioimmunoassay in systemic lupus erythematosus. Arthritis Rheum. 1985 Oct;28(10):1122–1127. doi: 10.1002/art.1780281007. [DOI] [PubMed] [Google Scholar]
  42. Lahita R. G. Sex steroids and the rheumatic diseases. Arthritis Rheum. 1985 Feb;28(2):121–126. doi: 10.1002/art.1780280202. [DOI] [PubMed] [Google Scholar]
  43. Lavalle C., Loyo E., Paniagua R., Bermudez J. A., Herrera J., Graef A., Gonzalez-Barcena D., Fraga A. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol. 1987 Apr;14(2):268–272. [PubMed] [Google Scholar]
  44. Lemire J. M., Adams J. S., Kermani-Arab V., Bakke A. C., Sakai R., Jordan S. C. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol. 1985 May;134(5):3032–3035. [PubMed] [Google Scholar]
  45. Lotze M. T., Frana L. W., Sharrow S. O., Robb R. J., Rosenberg S. A. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J Immunol. 1985 Jan;134(1):157–166. [PubMed] [Google Scholar]
  46. Lumpkin M. D. The regulation of ACTH secretion by IL-1. Science. 1987 Oct 23;238(4826):452–454. doi: 10.1126/science.2821618. [DOI] [PubMed] [Google Scholar]
  47. Mason R. S., Frankel T., Chan Y. L., Lissner D., Posen S. Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med. 1984 Jan;100(1):59–61. doi: 10.7326/0003-4819-100-1-59. [DOI] [PubMed] [Google Scholar]
  48. Mathews P. M., Froelich C. J., Sibbitt W. L., Jr, Bankhurst A. D. Enhancement of natural cytotoxicity by beta-endorphin. J Immunol. 1983 Apr;130(4):1658–1662. [PubMed] [Google Scholar]
  49. McCain H. W., Lamster I. B., Bozzone J. M., Grbic J. T. Beta-endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sci. 1982 Oct 11;31(15):1619–1624. doi: 10.1016/0024-3205(82)90054-6. [DOI] [PubMed] [Google Scholar]
  50. Payan D. G., Brewster D. R., Goetzl E. J. Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. J Immunol. 1984 Dec;133(6):3260–3265. [PubMed] [Google Scholar]
  51. Polla B. S., Healy A. M., Amento E. P., Krane S. M. 1,25-Dihydroxyvitamin D3 maintains adherence of human monocytes and protects them from thermal injury. J Clin Invest. 1986 Apr;77(4):1332–1339. doi: 10.1172/JCI112438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Provvedini D. M., Deftos L. J., Manolagas S. C. 1,25-Dihydroxyvitamin D3 receptors in a subset of mitotically active lymphocytes from rat thymus. Biochem Biophys Res Commun. 1984 May 31;121(1):277–283. doi: 10.1016/0006-291x(84)90719-8. [DOI] [PubMed] [Google Scholar]
  53. Provvedini D. M., Tsoukas C. D., Deftos L. J., Manolagas S. C. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol. 1986 Apr 15;136(8):2734–2740. [PubMed] [Google Scholar]
  54. Provvedini D. M., Tsoukas C. D., Deftos L. J., Manolagas S. C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983 Sep 16;221(4616):1181–1183. doi: 10.1126/science.6310748. [DOI] [PubMed] [Google Scholar]
  55. Rigby W. F., Denome S., Fanger M. W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest. 1987 Jun;79(6):1659–1664. doi: 10.1172/JCI113004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Rigby W. F., Noelle R. J., Krause K., Fanger M. W. The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol. 1985 Oct;135(4):2279–2286. [PubMed] [Google Scholar]
  57. Roosth J., Pollard R. B., Brown S. L., Meyer W. J., 3rd Cortisol stimulation by recombinant interferon-alpha 2. J Neuroimmunol. 1986 Oct;12(4):311–316. doi: 10.1016/0165-5728(86)90037-8. [DOI] [PubMed] [Google Scholar]
  58. Smith E. M., Meyer W. J., Blalock J. E. Virus-induced corticosterone in hypophysectomized mice: a possible lymphoid adrenal axis. Science. 1982 Dec 24;218(4579):1311–1312. doi: 10.1126/science.6183748. [DOI] [PubMed] [Google Scholar]
  59. Smith E. M., Morrill A. C., Meyer W. J., 3rd, Blalock J. E. Corticotropin releasing factor induction of leukocyte-derived immunoreactive ACTH and endorphins. 1986 Jun 26-Jul 2Nature. 321(6073):881–882. doi: 10.1038/321881a0. [DOI] [PubMed] [Google Scholar]
  60. Steffen M., Cayre Y., Manogue K. R., Moore M. A. 1,25-Dihydroxyvitamin D3 transcriptionally regulates tumour necrosis factor mRNA during HL-60 cell differentiation. Immunology. 1988 Jan;63(1):43–46. [PMC free article] [PubMed] [Google Scholar]
  61. Tabata T., Suzuki R., Kikunami K., Matsushita Y., Inoue T., Inoue T., Okamoto T., Miki T., Nishizawa Y., Morii H. The effect of 1 alpha-hydroxyvitamin D3 on cell-mediated immunity in hemodialyzed patients. J Clin Endocrinol Metab. 1986 Nov;63(5):1218–1221. doi: 10.1210/jcem-63-5-1218. [DOI] [PubMed] [Google Scholar]
  62. Tsoukas C. D., Provvedini D. M., Manolagas S. C. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984 Jun 29;224(4656):1438–1440. doi: 10.1126/science.6427926. [DOI] [PubMed] [Google Scholar]
  63. Westly H. J., Kleiss A. J., Kelley K. W., Wong P. K., Yuen P. H. Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med. 1986 Jun 1;163(6):1589–1594. doi: 10.1084/jem.163.6.1589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Wybran J. Enkephalins and endorphins as modifiers of the immune system: present and future. Fed Proc. 1985 Jan;44(1 Pt 1):92–94. [PubMed] [Google Scholar]
  65. Yetgin S., Ozsoylu S. Myeloid metaplasia in vitamin D deficiency rickets. Scand J Haematol. 1982 Feb;28(2):180–185. doi: 10.1111/j.1600-0609.1982.tb00512.x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES